In re: Entresto (Sacubitril/Valsartan) Patent Litigation

1:2020-md-02930
ANDA
Bio-Tech
Cause of ActionLogin To View
Appeal NumberLogin To View
StatusLogin To View
OutcomeSubscription-Only
Patent
4
09388134081016590887793808796331
Filing DateMar 27, 2020
Termination DateLogin To View
CourtLogin To View
JudgesLogin To View
Case LengthLogin To View
Technology Center-
Plaintiff
4
Novartis
Msn Laboratories
Biocon
Defendant
4
Noratech Labs Inc.
Hetero
Alembic Pharmaceuticals Ltd.
ANDA report image

Empower your practice with Patexia ANDA IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a ANDA Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.